Newsfile Corp
02 Jul 2026, 22:30 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GeneDx experienced a $31.3 million impairment loss directly attributed to its acquisition of Fabric Genomics. — A significant impairment charge indicates a failure of a strategic acquisition and immediate loss of asset value.
-0.70GeneDx reduced its projected earnings from a range of $540-$555 million down to $475-$490 million. — Downward revisions of earnings guidance typically trigger immediate negative price action and lower valuation multiples.
-0.60GeneDx's adjusted gross margin dropped from 74% to 69% in the first quarter of 2026. — Margin compression suggests deteriorating operational efficiency or increased costs of delivery.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
A class action lawsuit has been filed alleging that GeneDx executives made false or misleading statements regarding the viability of Fabric Genomics. — Securities litigation creates long-term legal liabilities and damages management credibility with investors.
Which stocks this story touches
The company is mentioned in an investor notice regarding a class action lawsuit for investors with substantial losses.
The company is facing a class action lawsuit alleging securities fraud and reporting a significant stock price drop and impairment losses.
The company is mentioned in an investor alert regarding a class action lawsuit for investors with substantial losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
3h ago
